Question · asked by 1 review
COMPARISON 1. ARIPIPRAZOLE vs ZIPRASIDONE: Quality of life ‐ not measured
- Population
- patients with schizophrenia
- Intervention
- COMPARISON 1. ARIPIPRAZOLE
- Comparison
- ZIPRASIDONE
- Outcome
- Quality of life ‐ not measured
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
COMPARISON 4. ARIPIPRAZOLE vs ZIPRASIDONE Quality of life ‐ not measured · patients with schizophrenia The review found no eligible studies for this question. Aripiprazole versus other atypical antipsychotics for schizophrenia (2014) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Aripiprazole versus other atypical antipsychotics for schizophrenia 2014 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- COMPARISON 1. ARIPIPRAZOLE vs RISPERIDONE · patients with schizophrenia · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.